Similar articles for PMID: 32056235

Year	Number of Results
2015	1
2020	99
2021	3
2024	0

1

Does SARS-CoV-2 has a longer incubation period than SARS and MERS?

Jiang X, Rayner S, Luo MH. Jiang X, et al. J Med Virol. 2020 May;92(5):476-478. doi: 10.1002/jmv.25708. Epub 2020 Feb 24. J Med Virol. 2020. PMID: 32056235 Free PMC article.

2

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.

Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, Trilling M, Lu M, Dittmer U, Yang D. Liu J, et al. J Med Virol. 2020 May;92(5):491-494. doi: 10.1002/jmv.25709. Epub 2020 Feb 21. J Med Virol. 2020. PMID: 32056249 Free PMC article. Review.

3

The reproductive number of COVID-19 is higher compared to SARS coronavirus.

Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. Liu Y, et al. J Travel Med. 2020 Mar 13;27(2):taaa021. doi: 10.1093/jtm/taaa021. J Travel Med. 2020. PMID: 32052846 Free PMC article. Review. No abstract available.

4

Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?

Elrashdy F, Redwan EM, Uversky VN. Elrashdy F, et al. Biomolecules. 2020 Sep 11;10(9):1312. doi: 10.3390/biom10091312. Biomolecules. 2020. PMID: 32933047 Free PMC article. Review.

5

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.

Abdelrahman Z, Li M, Wang X. Abdelrahman Z, et al. Front Immunol. 2020 Sep 11;11:552909. doi: 10.3389/fimmu.2020.552909. eCollection 2020. Front Immunol. 2020. PMID: 33013925 Free PMC article. Review.

6

Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.

Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS. Halaji M, et al. Infez Med. 2020 Jun 1;28(suppl 1):6-17. Infez Med. 2020. PMID: 32532933 Free article. Review.

7

[Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].

Liu M, Feng RE, Li Q, Zhang HK, Wang YG. Liu M, et al. Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):511-516. doi: 10.3760/cma.j.cn112151-20200301-00155. Zhonghua Bing Li Xue Za Zhi. 2020. PMID: 32392945 Chinese.

8

Remdesivir against COVID-19 and Other Viral Diseases.

Malin JJ, Suárez I, Priesner V, Fätkenheuer G, Rybniker J. Malin JJ, et al. Clin Microbiol Rev. 2020 Oct 14;34(1):e00162-20. doi: 10.1128/CMR.00162-20. Print 2020 Dec 16. Clin Microbiol Rev. 2020. PMID: 33055231 Free PMC article. Review.

9

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.

Liang Y, Wang ML, Chien CS, Yarmishyn AA, Yang YP, Lai WY, Luo YH, Lin YT, Chen YJ, Chang PC, Chiou SH. Liang Y, et al. Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020. Front Immunol. 2020. PMID: 32574260 Free PMC article. Review.

10

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. Guo YR, et al. Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0. Mil Med Res. 2020. PMID: 32169119 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year